eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

vol. 23
Review paper

The role of nutrition in the treatment of irritable bowel syndrome

Antoine Aoun
Jessica Maalouf
Sara Khalil
Veronique El Khoury

Medical Center and Department of Nursing and Health Sciences, Notre Dame University-Louaize, Zouk Mosbeh, Lebanon
Department of Nursing and Health Sciences, Notre Dame University-Louaize, Zouk Mosbeh, Lebanon
Family Medicine & Primary Care Review 2021; 23(4): 495–500
Online publish date: 2021/10/05
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
1. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016; 150(6): 1393–1407.
2. Wald A. Clinical manifestations and diagnosis of irritable bowel syndrome in adults. UpToDate. 2019 [cited 1.12.2020]. Available from URL: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-irritable-bowel-syndrome-in-adults?topicRef=2631& source=see_link#H2263560866.
3. Chey WD, Kurlander J, Eswaran S. Irritable Bowel Syndrome a clinical review. JAMA 2015; 313: 949–958. 
4. Sperber AD, Dumitrascu D, Fukudo S, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut 2017; 66(6): 1075–1082.
5. Zannini E, Arendt EK. Low FODMAPs and gluten-free foods for irritable bowel syndrome treatment: lights and shadows. Food Res Int 2018; 110: 33–41.
6. Asha MZ, Khalil SFH. Efficacy and safety of probiotics, prebiotics and synbiotics in the treatment of Irritable Bowel Syndrome: a systematic review and meta-analysis. Sultan Qaboos Univ Med J 2020; 20(1): e13–e24.
7. Ireton-Jones C, Weisberg MF. Management of Irritable Bowel Syndrome: physician-dietitian collaboration. NCP 2020; 35(5), doi: 10.1002/ncp.10567.
8. Fadgyas-Stanculete M, Dumitrascu DL, Pojoga C, et al. Coping strategies and dysfunctional cognitions as predictors of irritable bowel syndrome diagnosis. JCBPR 2015; 15(1): 111.
9. Clinical practice guideline irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care National Collaborating Centre for Nursing and Supportive Care commissioned by National Institute for Health and Clinical Excellence. 2008 Feb. [cited 15.12.2020]. Available from URL: https://www.nice.org.uk/guidance/cg61/evidence/full-guidance-pdf-196701661.
10. Chumpitazi BP, Self MM, Czyzewski DI, et al. Bristol Stool Form Scale reliability and agreement decreases when determining Rome III Stool Form Designations. Neurogastroenterol Motil 2016; 28(3): 443–448.
11. Wald A. Treatment of irritable bowel syndrome in adults. UpToDate. 2020 [cited 15.12.2020]. Available from URL: https://www.uptodate.com/contents/treatment-of-irritable-bowel-syndrome-in-adults.
12. Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014; 109(S1): S2.
13. Portincasa P, Bonfrate L, de Bari O, et al. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf) 2017; 5(1): 11–19. 
14. Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterologica e Dietologica 2020; 66(2): 136–150.
15. Canakis A, Haroon M, Weber HC. Irritable bowel syndrome and gut microbiota. Curr Opin Endocrinol Diabetes Obes 2020; 27(1): 28–35.
16. Pimentel M, Lembo A. Microbiome and its role in Irritable Bowel Syndrome. Dig Dis Sci 2020; 65(3): 829–839.
17. Major G, Pritchard S, Murray K, et al. Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with Irritable Bowel Syndrome. Gastroenterology 2017; 152(1): 124–133.
18. Yang J, Deng Y, Chu H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2013; 11(3): 262–268.
19. Liu J, Chey WD, Haller E, et al. Low-FODMAP diet for Irritable Bowel Syndrome: what we know and what we have yet to learn. Annu Rev of Med 2020; 71: 303–314.
20. Singh R, Salem A, Nanavati J, et al. The role of diet in the treatment of irritable bowel syndrome: a systematic review. Gastroenterol Clin North Am 2018; 47(1): 107–137.
21. Chey WD. Food: the main course to wellness and illness in patients with Irritable Bowel Syndrome. Am J Gastroenterol 2016; 111(3): 366–371.
22. Dugum M, Barco K, Garg S. Managing irritable bowel syndrome: the low-FODMAP diet. Cleve Clin J Med 2016; 83(9): 655–662.
23. Whelan K, Martin LD, Staudacher HM, et al. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018; 31(2): 239–255.
24. Nanayakkara WS, Skidmore PM, O’Brien L, et al. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol 2016; 9: 131–142.
25. McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2016; 66(7): 1241–1251.
26. Eswaran SL, Chey WD, Han-Markey T, et al. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016; 111(12): 1824.
27. Gravina AG, Dallio M, Romeo M, et al. Adherence and effects derived from FODMAP diet on Irritable Bowel Syndrome: a real life evaluation of a large follow-up observation. Nutrients 2020; 12(4): 928.
28. Clevers E, Tran M, Van Oudenhove L, et al. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome. Nutrition 2020; 73: 110719.
29. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015; 149(6): 1399–1407.
30. Altobelli E, Del Negro V, Angeletti PM, et al. Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis. Nutrients 2017; 9(9): 940.
31. Cozma-Petruţ A, Loghin F, Miere D, et al. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients! World J Gastroenterol 2017; 23(21): 3771.
32. Barone M, Gemello E, Viggiani MT, et al. Evaluation of non-celiac gluten sensitivity in patients with previous diagnosis of Irritable Bowel Syndrome: a randomized double-blind placebo-controlled crossover trial. Nutrients 2020; 12(3): 705.
33. Skodje G, Sarna V, Minelle I, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology 2018; 154(3): 529–539.
34. Biesiekierski JR, Iven J. Non-coeliac gluten sensitivity: piecing the puzzle together. United European Gastroenterol J 2015; 3(2): 160–165.
35. Makharia A, Catassi C, Makharia GK. The overlap between irritable bowel syndrome and non-celiac gluten sensitivity: a clinical dilemma. Nutrients 2015; 7(12): 10417–10426. 
36. Volta U, Pinto-Sanchez MI, Boschetti E, et al. Dietary triggers in irritable bowel syndrome: is there a role for gluten? J Neurogastroenterol Motil 2016; 22(4): 547–557.
37. Yan YL, Hu Y, Gänzle MG. Prebiotics, FODMAPs and dietary fiber-conflicting concepts in development of functional food products? COFS 2018; 20: 30–37.
38. El-Salhy M, Ystad SO, Mazzawi T, et al. Dietary fiber in irritable bowel syndrome (review). Int J Mol Med 2017; 40(3): 607–613.
39. McRorie JW. Evidence-based approach to fiber supplements and clinically meaningful health benefits, Part 2. Nutr Today 2015; 50(2): 90–97.
40. Moayyedi P, Quigley EM, Lacy B, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2014; 109(9): 1367–1374.
41. Reding KW, Cain KC, Jarrett ME, et al. Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome. Am J Gastroenterol 2013; 108(2): 270–276.
42. Swanson GR, Sedghi S, Farhadi A, et al. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol 2010; 44(3): 223–228.
43. U.S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans. 8th Edition. 2015. Available from URL: https://health.gov/sites/default/files/2019-09/2015-2020_Dietary_Guidelines.pdf.
44. McKenzie YA, Bowyer RK, Leach H et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016; 29(5): 549–575.
45. Capili B, Anastasi JK, Chang M. Addressing the role of food in Irritable Bowel Syndrome symptom management. J Nurse Pract 2016; 12(5): 324–329.
46. Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475–486. 
47. Zhang Y, Li L, Guo C, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol 2016; 16(1): 62. 
48. Lackner JM, Jaccard J, Keefer L, et al. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory Irritable Bowel Syndrome. Gastroenterology 2018; 155(1): 47–57.
49. Gendi R, Jahan N. Pharmacological and non-pharmacological treatments of Irritable Bowel Syndrome and their impact on the quality of life: a literature review. Cureus 2020; 12(7): e9324.
50. Lacy BE, Chey WD, Lembo AJ. New and emerging treatment options for Irritable Bowel Syndrome. Gastroenterol Hepatol (NY) 2015; 11: 1–19.
Copyright: © 2021 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.